chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: muscle pain over lower back and was going up to shoulder and neck; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain over lower back and was going up to shoulder and neck) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced MYALGIA (muscle pain over lower back and was going up to shoulder and neck). The patient was treated with PARACETAMOL (TYLENOL) for Myalgia, at an unspecified dose and frequency. At the time of the report, MYALGIA (muscle pain over lower back and was going up to shoulder and neck) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea
Clinical narrative: shortness of breath, blew up today/I still have shortness of breath when getting up from sitting or bending; dizziness, blew up today; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath, blew up today/I still have shortness of breath when getting up from sitting or bending) and DIZZINESS (dizziness, blew up today) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced DYSPNOEA (shortness of breath, blew up today/I still have shortness of breath when getting up from sitting or bending) and DIZZINESS (dizziness, blew up today). At the time of the report, DYSPNOEA (shortness of breath, blew up today/I still have shortness of breath when getting up from sitting or bending) had not resolved and DIZZINESS (dizziness, blew up today) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included Blood pressure medication currently not taking. Treatment medication not provided. Patient was drinking a lot of water and sitting down to manage reported events. Patient had major tests done on her heart and everything is fine.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow up received on  16 Jul 2021 included lab data, outcome of the event is still ongoing for shortness of breath.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Pain in extremity
Clinical narrative: Sore arm; back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain) and PAIN IN EXTREMITY (Sore arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included No adverse event (No relevant medical history provided.).   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced BACK PAIN (back pain). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with METHOCARBAMOL ongoing since an unknown date for Muscle pain, at a dose of 2 tablets four times daily as needed She is taking every 6-7 hours half a tablet. At the time of the report, BACK PAIN (back pain) had not resolved and PAIN IN EXTREMITY (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-073898 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073898:Dose 2 of vaccine
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Mass, Pain in extremity, Pruritus, Rash
Clinical narrative: sore arm; bump on back of her head; swollen lymph nodes on the left side behind her ear; her scalp was itchy; she had a rash at the injection site; eventually she was diagnosed with an "all-over body rash"; hives were concentrated on her legs and scalps; lesser degree of hives on her back, abdomen, and arm; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), MASS (bump on back of her head), LYMPHADENOPATHY (swollen lymph nodes on the left side behind her ear), PRURITUS (her scalp was itchy) and VACCINATION SITE RASH (she had a rash at the injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history provided). Concomitant products included MULTIVITAMIN & MINERAL, METOPROLOL and TOCOPHEROL (VITAMIN E FORMULA) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), MASS (bump on back of her head), LYMPHADENOPATHY (swollen lymph nodes on the left side behind her ear), PRURITUS (her scalp was itchy), VACCINATION SITE RASH (she had a rash at the injection site), RASH (eventually she was diagnosed with an "all-over body rash"), URTICARIA (hives were concentrated on her legs and scalps) and URTICARIA (lesser degree of hives on her back, abdomen, and arm). At the time of the report, PAIN IN EXTREMITY (sore arm), MASS (bump on back of her head), LYMPHADENOPATHY (swollen lymph nodes on the left side behind her ear), PRURITUS (her scalp was itchy), VACCINATION SITE RASH (she had a rash at the injection site), RASH (eventually she was diagnosed with an "all-over body rash"), URTICARIA (hives were concentrated on her legs and scalps) and URTICARIA (lesser degree of hives on her back, abdomen, and arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that the doctor prescribed her steroids and cetirizine (Zyrtec) to treat the events.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site rash
Clinical narrative: sore arm; bump on back of her head; swollen lymph nodes on the left side behind her ear; her scalp was itchy; she had a rash at the injection site; eventually she was diagnosed with an "all-over body rash"; hives were concentrated on her legs and scalps; lesser degree of hives on her back, abdomen, and arm; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), MASS (bump on back of her head), LYMPHADENOPATHY (swollen lymph nodes on the left side behind her ear), PRURITUS (her scalp was itchy) and VACCINATION SITE RASH (she had a rash at the injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history provided). Concomitant products included MULTIVITAMIN & MINERAL, METOPROLOL and TOCOPHEROL (VITAMIN E FORMULA) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), MASS (bump on back of her head), LYMPHADENOPATHY (swollen lymph nodes on the left side behind her ear), PRURITUS (her scalp was itchy), VACCINATION SITE RASH (she had a rash at the injection site), RASH (eventually she was diagnosed with an "all-over body rash"), URTICARIA (hives were concentrated on her legs and scalps) and URTICARIA (lesser degree of hives on her back, abdomen, and arm). At the time of the report, PAIN IN EXTREMITY (sore arm), MASS (bump on back of her head), LYMPHADENOPATHY (swollen lymph nodes on the left side behind her ear), PRURITUS (her scalp was itchy), VACCINATION SITE RASH (she had a rash at the injection site), RASH (eventually she was diagnosed with an "all-over body rash"), URTICARIA (hives were concentrated on her legs and scalps) and URTICARIA (lesser degree of hives on her back, abdomen, and arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that the doctor prescribed her steroids and cetirizine (Zyrtec) to treat the events.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch around injection site), VACCINATION SITE PRURITUS (Itchy around injection site), VACCINATION SITE ERYTHEMA (Redness around injection site), VACCINATION SITE PAIN (Hurts around injection site) and VACCINATION SITE RASH ("Looks like a rash") in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. No Medical History information was reported. On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy around injection site) and VACCINATION SITE ERYTHEMA (Redness around injection site). On 12-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch around injection site), VACCINATION SITE PAIN (Hurts around injection site) and VACCINATION SITE RASH ("Looks like a rash"). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch around injection site), VACCINATION SITE PRURITUS (Itchy around injection site), VACCINATION SITE ERYTHEMA (Redness around injection site), VACCINATION SITE PAIN (Hurts around injection site) and VACCINATION SITE RASH ("Looks like a rash") had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications provided. No treatment medications were provided. Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up received on 12-MAY-2021 Event details updated.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Myalgia, Nausea
Clinical narrative: Sweating; Body aches; chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), MYALGIA (Body aches), CHILLS (chills) and NAUSEA (Nausea) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02YM20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), MYALGIA (Body aches), CHILLS (chills) and NAUSEA (Nausea). At the time of the report, HYPERHIDROSIS (Sweating), MYALGIA (Body aches), CHILLS (chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness some days after the first shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness some days after the first shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness some days after the first shot). At the time of the report, DIZZINESS (dizziness some days after the first shot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment or concomitant information was provided   This case was linked to US-MODERNATX, INC.-MOD-2021-073835 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073835:Patient's case
Sex: F
Vaccine: COVID19
Symptoms: Lip pain, Oropharyngeal pain, Pyrexia, Rash, White blood cell count
Clinical narrative: elevated WBC; sore throat when she swallows; fever; rash; sores on her lip; This spontaneous case was reported by a patient and describes the occurrence of RASH (rash), WHITE BLOOD CELL COUNT INCREASED (elevated WBC), LIP PAIN (sores on her lip), PYREXIA (fever) and OROPHARYNGEAL PAIN (sore throat when she swallows) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced RASH (rash) and LIP PAIN (sores on her lip). On 01-Apr-2021, the patient experienced PYREXIA (fever). On 03-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat when she swallows). On 06-Apr-2021, the patient experienced WHITE BLOOD CELL COUNT INCREASED (elevated WBC). At the time of the report, RASH (rash), WHITE BLOOD CELL COUNT INCREASED (elevated WBC), LIP PAIN (sores on her lip), PYREXIA (fever) and OROPHARYNGEAL PAIN (sore throat when she swallows) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. Caller stated the was prescribed antibiotics on 12APR2021, which have not been started.
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: elevated WBC; sore throat when she swallows; fever; rash; sores on her lip; This spontaneous case was reported by a patient and describes the occurrence of RASH (rash), WHITE BLOOD CELL COUNT INCREASED (elevated WBC), LIP PAIN (sores on her lip), PYREXIA (fever) and OROPHARYNGEAL PAIN (sore throat when she swallows) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced RASH (rash) and LIP PAIN (sores on her lip). On 01-Apr-2021, the patient experienced PYREXIA (fever). On 03-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat when she swallows). On 06-Apr-2021, the patient experienced WHITE BLOOD CELL COUNT INCREASED (elevated WBC). At the time of the report, RASH (rash), WHITE BLOOD CELL COUNT INCREASED (elevated WBC), LIP PAIN (sores on her lip), PYREXIA (fever) and OROPHARYNGEAL PAIN (sore throat when she swallows) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. Caller stated the was prescribed antibiotics on 12APR2021, which have not been started.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: Warm to touch; Itchy; Rash 4 inches long by 4 inches wide; Injection site some redness; Some tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash 4 inches long by 4 inches wide), INJECTION SITE ERYTHEMA (Injection site some redness) and VACCINATION SITE PAIN (Some tenderness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 001B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash 4 inches long by 4 inches wide), INJECTION SITE ERYTHEMA (Injection site some redness) and VACCINATION SITE PAIN (Some tenderness). At the time of the report, VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash 4 inches long by 4 inches wide), INJECTION SITE ERYTHEMA (Injection site some redness) and VACCINATION SITE PAIN (Some tenderness) outcome was unknown.            Concomitant medication was not provided. Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: did not receive second dose; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (did not receive second dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided).   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not receive second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (did not receive second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: No specific follow-up information recorded.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Illness, Injection site pain, Insomnia
Clinical narrative: Lethargy; tired; the rash had spread from head to toe; felt really ill; awake for 48hrs, they had not slept; felt really bad; rash on the left forearm that was really itchy; soreness of the arm of the injection; This spontaneous case was reported by a physician and describes the occurrence of LETHARGY (Lethargy), FATIGUE (tired), INJECTION SITE PAIN (soreness of the arm of the injection), FEELING ABNORMAL (felt really bad) and RASH (the rash had spread from head to toe) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product AMLODIPINE for an unknown indication.    No medical history was provided by reporter.  Concomitant products included CANDESARTAN, PANTOPRAZOLE and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started AMLODIPINE (unknown route) at an unspecified dose. On 16-Mar-2021, the patient experienced INJECTION SITE PAIN (soreness of the arm of the injection). On 18-Mar-2021, the patient experienced FEELING ABNORMAL (felt really bad) and RASH (rash on the left forearm that was really itchy). On 19-Mar-2021, the patient experienced ILLNESS (felt really ill) and INSOMNIA (awake for 48hrs, they had not slept). On 20-Mar-2021, the patient experienced RASH (the rash had spread from head to toe). On an unknown date, the patient experienced LETHARGY (Lethargy) and FATIGUE (tired). On 21-Mar-2021, INSOMNIA (awake for 48hrs, they had not slept) had resolved. At the time of the report, INJECTION SITE PAIN (soreness of the arm of the injection), FEELING ABNORMAL (felt really bad), RASH (the rash had spread from head to toe), ILLNESS (felt really ill) and RASH (rash on the left forearm that was really itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-073738 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: No specific follow-up information recorded.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073738:Patient's case
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Rash
Clinical narrative: Lethargy; tired; the rash had spread from head to toe; felt really ill; awake for 48hrs, they had not slept; felt really bad; rash on the left forearm that was really itchy; soreness of the arm of the injection; This spontaneous case was reported by a physician and describes the occurrence of LETHARGY (Lethargy), FATIGUE (tired), INJECTION SITE PAIN (soreness of the arm of the injection), FEELING ABNORMAL (felt really bad) and RASH (the rash had spread from head to toe) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product AMLODIPINE for an unknown indication.    No medical history was provided by reporter.  Concomitant products included CANDESARTAN, PANTOPRAZOLE and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started AMLODIPINE (unknown route) at an unspecified dose. On 16-Mar-2021, the patient experienced INJECTION SITE PAIN (soreness of the arm of the injection). On 18-Mar-2021, the patient experienced FEELING ABNORMAL (felt really bad) and RASH (rash on the left forearm that was really itchy). On 19-Mar-2021, the patient experienced ILLNESS (felt really ill) and INSOMNIA (awake for 48hrs, they had not slept). On 20-Mar-2021, the patient experienced RASH (the rash had spread from head to toe). On an unknown date, the patient experienced LETHARGY (Lethargy) and FATIGUE (tired). On 21-Mar-2021, INSOMNIA (awake for 48hrs, they had not slept) had resolved. At the time of the report, INJECTION SITE PAIN (soreness of the arm of the injection), FEELING ABNORMAL (felt really bad), RASH (the rash had spread from head to toe), ILLNESS (felt really ill) and RASH (rash on the left forearm that was really itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-073738 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: No specific follow-up information recorded.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073738:Patient's case
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Joint stiffness, Rash
Clinical narrative: Mild headaches; Joints hurt when lifting the arm; Tightness on the Shoulder; Rash on the Thighs; Rash on the feet; Rash on the stomach; Shoulder Soreness; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (Tightness on the Shoulder), RASH (Rash on the Thighs), RASH (Rash on the feet), RASH (Rash on the stomach) and ARTHRALGIA (Shoulder Soreness) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced JOINT STIFFNESS (Tightness on the Shoulder), RASH (Rash on the Thighs), RASH (Rash on the feet), RASH (Rash on the stomach), ARTHRALGIA (Shoulder Soreness) and ARTHRALGIA (Joints hurt when lifting the arm). On an unknown date, the patient experienced HEADACHE (Mild headaches). On 25-Mar-2021, RASH (Rash on the Thighs), RASH (Rash on the feet) and RASH (Rash on the stomach) had resolved. At the time of the report, JOINT STIFFNESS (Tightness on the Shoulder), ARTHRALGIA (Shoulder Soreness), HEADACHE (Mild headaches) and ARTHRALGIA (Joints hurt when lifting the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Pain in extremity, Pyrexia
Clinical narrative: right arm hurt; felt low energy; developed a fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (right arm hurt), ASTHENIA (felt low energy) and PYREXIA (developed a fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 031L20A) for COVID-19 vaccination.     The patient's past medical history included Lung cancer in 1997, Lymphedema, Vocal cord paralysis and Bronchoscopy. Concurrent medical conditions included Penicillin allergy.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (right arm hurt), ASTHENIA (felt low energy) and PYREXIA (developed a fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 15-Mar-2021, PYREXIA (developed a fever) had resolved. On 18-Mar-2021, PAIN IN EXTREMITY (right arm hurt) and ASTHENIA (felt low energy) had resolved.            Patient had received surgery, chemotherapy, and radiation (1997,1998, and 1999) for Lung Cancer and Teflon injection in 2002 to treat her paralyzed vocal cord   Concomitant medication for thyroid maintenance was not specified.   This case was linked to MOD21-073396 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Follow up was received contains no new information
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Pyrexia
Clinical narrative: Cough; Fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (Cough) and PYREXIA (Fever) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced COUGH (Cough) and PYREXIA (Fever). At the time of the report, COUGH (Cough) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was on unspecified medications for high blood pressure.   The patient's healthcare provider told him to rest, hydrate, and to take Tylenol or ibuprofen.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia
Clinical narrative: headaches; slight fever; body aches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches), PYREXIA (slight fever), PAIN (body aches) and NAUSEA (nausea) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HEADACHE (headaches), PYREXIA (slight fever), PAIN (body aches) and NAUSEA (nausea). At the time of the report, HEADACHE (headaches), PYREXIA (slight fever), PAIN (body aches) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Swelling
Clinical narrative: Swelling of Knuckles of right hand; Cannot make fist; Soreness in Knuckles of right hand; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling of Knuckles of right hand), PAIN (Cannot make fist) and MYALGIA (Soreness in Knuckles of right hand) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling of Knuckles of right hand), PAIN (Cannot make fist) and MYALGIA (Soreness in Knuckles of right hand). At the time of the report, SWELLING (Swelling of Knuckles of right hand), PAIN (Cannot make fist) and MYALGIA (Soreness in Knuckles of right hand) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present, Diarrhoea
Clinical narrative: diarrhea; blood in urine; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and BLOOD URINE PRESENT (blood in urine) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04021A) for COVID-19 immunization.     Concurrent medical conditions included Prostatic disorder and Cholesterol.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea) and BLOOD URINE PRESENT (blood in urine). At the time of the report, DIARRHOEA (diarrhea) and BLOOD URINE PRESENT (blood in urine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported. Concomitant medications were reported for prostate and cholesterol but not specified. Patient wanted to know if he should get second dose tomorrow given the symptoms and prostate treatment.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Myalgia, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), CHILLS (chills), MYALGIA (Body Aches) and NAUSEA (Nausea) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02YM20A) for COVID-19 vaccination. The patient's past medical history included No adverse reaction. On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), CHILLS (chills), MYALGIA (Body Aches) and NAUSEA (Nausea). At the time of the report, HYPERHIDROSIS (Sweating), CHILLS (chills), MYALGIA (Body Aches) and NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route), the reporter did not provide any causality assessments. Concomitant product is not provided. Treatment is not provided.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Nasopharyngitis, Rhinorrhoea
Clinical narrative: cold; a stuffy and runny nose; felt run down; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), RHINORRHOEA (a stuffy and runny nose) and FATIGUE (felt run down) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced FATIGUE (felt run down). On 12-Apr-2021, the patient experienced NASOPHARYNGITIS (cold) and RHINORRHOEA (a stuffy and runny nose). At the time of the report, NASOPHARYNGITIS (cold), RHINORRHOEA (a stuffy and runny nose) and FATIGUE (felt run down) outcome was unknown.            No treatments reported. No Concomitant medications reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain in extremity, Product dose omission issue
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well), PAIN IN EXTREMITY (Legs hurt really bad) and PRODUCT DOSE OMISSION ISSUE (61 days post first shot) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. Concurrent medical conditions included Neuropathic pain, Blood pressure and Cholesterol. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (61 days post first shot). On an unknown date, the patient experienced MALAISE (Not feeling well) and PAIN IN EXTREMITY (Legs hurt really bad). At the time of the report, MALAISE (Not feeling well) and PAIN IN EXTREMITY (Legs hurt really bad) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (61 days post first shot) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. In the follow up it t was reported that patients leg pain is not due to the vaccine. Concomitant medication including blood pressure medicine, cholesterol medicine and pain medicine was reported. Treatment using pain killer medicine that the patient  takes every day for pain in the leg (no name specified) was reported. Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Additional Information received and Medical History Neuropathic pain was added. New "event 61 days post first shot" was added.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Vaccination complication
Clinical narrative: Bad reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Bad reaction) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Smoker.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Bad reaction). At the time of the report, VACCINATION COMPLICATION (Bad reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: increased (High) Blood pressure spike.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This patient was in her 60s. No relevant concomitant medications were provided. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient received the first vaccine at the end of December and never received the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received the first vaccine at the end of December and never received the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2020, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received the first vaccine at the end of December and never received the second dose). In December 2020, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received the first vaccine at the end of December and never received the second dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided. Treatment information was not provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Nausea
Clinical narrative: no appetite; Chills; bad headache; Body aches; Nausea, no appetite; Tired and fatigued; Injection site became painful; Injection site became swollen; Injection site developed a 5 cm red patch; Injection site felt like it was having an allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad headache), PAIN (Body aches), NAUSEA (Nausea, no appetite), DECREASED APPETITE (no appetite) and FATIGUE (Tired and fatigued) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included Congestive Heart Failure Medications and Atrial Fibrillation Medications.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HEADACHE (bad headache), PAIN (Body aches), NAUSEA (Nausea, no appetite), FATIGUE (Tired and fatigued), VACCINATION SITE PAIN (Injection site became painful), VACCINATION SITE SWELLING (Injection site became swollen), VACCINATION SITE ERYTHEMA (Injection site developed a 5 cm red patch) and VACCINATION SITE REACTION (Injection site felt like it was having an allergic reaction). On 10-Apr-2021, the patient experienced CHILLS (Chills). On an unknown date, the patient experienced DECREASED APPETITE (no appetite). At the time of the report, HEADACHE (bad headache), PAIN (Body aches), NAUSEA (Nausea, no appetite), FATIGUE (Tired and fatigued), VACCINATION SITE PAIN (Injection site became painful), VACCINATION SITE SWELLING (Injection site became swollen), VACCINATION SITE ERYTHEMA (Injection site developed a 5 cm red patch), VACCINATION SITE REACTION (Injection site felt like it was having an allergic reaction) and CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site erythema, Vaccination site pain, Vaccination site reaction, Vaccination site swelling
Clinical narrative: no appetite; Chills; bad headache; Body aches; Nausea, no appetite; Tired and fatigued; Injection site became painful; Injection site became swollen; Injection site developed a 5 cm red patch; Injection site felt like it was having an allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad headache), PAIN (Body aches), NAUSEA (Nausea, no appetite), DECREASED APPETITE (no appetite) and FATIGUE (Tired and fatigued) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included Congestive Heart Failure Medications and Atrial Fibrillation Medications.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HEADACHE (bad headache), PAIN (Body aches), NAUSEA (Nausea, no appetite), FATIGUE (Tired and fatigued), VACCINATION SITE PAIN (Injection site became painful), VACCINATION SITE SWELLING (Injection site became swollen), VACCINATION SITE ERYTHEMA (Injection site developed a 5 cm red patch) and VACCINATION SITE REACTION (Injection site felt like it was having an allergic reaction). On 10-Apr-2021, the patient experienced CHILLS (Chills). On an unknown date, the patient experienced DECREASED APPETITE (no appetite). At the time of the report, HEADACHE (bad headache), PAIN (Body aches), NAUSEA (Nausea, no appetite), FATIGUE (Tired and fatigued), VACCINATION SITE PAIN (Injection site became painful), VACCINATION SITE SWELLING (Injection site became swollen), VACCINATION SITE ERYTHEMA (Injection site developed a 5 cm red patch), VACCINATION SITE REACTION (Injection site felt like it was having an allergic reaction) and CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: Muscle problem; Joint problem; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYALGIA (Muscle problem) and ARTHRALGIA (Joint problem) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LORATADINE (CLARITIN [LORATADINE]) and FUROSEMIDE for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Muscle problem) and ARTHRALGIA (Joint problem). At the time of the report, MYALGIA (Muscle problem) and ARTHRALGIA (Joint problem) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment provided included extra strength acetaminophen 500 mg and prednisone 10 mg for 5 days.    Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Reporter contact information updated.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Vaccination site pruritus
Clinical narrative: injection site itching; tired; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE PRURITUS (injection site itching) and FATIGUE (tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (tired). On 06-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itching). On 27-Feb-2021, PAIN IN EXTREMITY (sore arm) and FATIGUE (tired) had resolved. On 06-Mar-2021, VACCINATION SITE PRURITUS (injection site itching) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) was unknown.       No concomitant medications or treatment details were provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Musculoskeletal stiffness, Nausea, Pain in extremity, Rhinorrhoea
Clinical narrative: nausea; stomach pain; sore arm; stiff arm; runny nose; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), ABDOMINAL PAIN UPPER (stomach pain), PAIN IN EXTREMITY (sore arm), MUSCULOSKELETAL STIFFNESS (stiff arm) and RHINORRHOEA (runny nose) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 immunization.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included PROBIOTICS NOS and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced NAUSEA (nausea), ABDOMINAL PAIN UPPER (stomach pain), PAIN IN EXTREMITY (sore arm), MUSCULOSKELETAL STIFFNESS (stiff arm) and RHINORRHOEA (runny nose). At the time of the report, NAUSEA (nausea), ABDOMINAL PAIN UPPER (stomach pain), PAIN IN EXTREMITY (sore arm), MUSCULOSKELETAL STIFFNESS (stiff arm) and RHINORRHOEA (runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported.
Sex: F
Vaccine: COVID19
Symptoms: Hypertension
Clinical narrative: High Blood Pressure; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High Blood Pressure) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (High Blood Pressure). At the time of the report, HYPERTENSION (High Blood Pressure) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.